According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at UroGen Pharma are Director Ran Nussbaum (1.48Mn shares), Director Arie Belldegrun (408.69K shares), Chief Executive Officer Elizabeth A. Barrett (326.69K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ran Nussbaum | 1,481,927 | 25 Oct, 2022 | |
| Arie Belldegrun | 408,693 | 16 Sep, 2022 | |
| Elizabeth A. Barrett | Chief Executive Officer | 326,691 | 02 Feb, 2023 |
| Mark Schoenberg | Chief Medical Officer | 139,025 | 20 Nov, 2025 |
| Fred E Cohen | 69,339 | 28 Jul, 2023 | |
| Jason Drew Smith | General Counsel | 43,305 | 09 Sep, 2025 |
| Dong Kim | Chief Financial Officer | 37,753 | 12 Sep, 2024 |
| Molly Henderson | Chief Financial Officer | 5,248 | 02 Feb, 2022 |
| Chris Degnan | Chief Financial Officer | 2,280 | 09 Oct, 2025 |
| Daniel George Wildman | 2,000 | 01 Dec, 2025 | |
| James A. Jr. Robinson | 2,000 | 01 Dec, 2025 | |
| Stuart Holden | 2,000 | 01 Dec, 2025 | |
| Leana Wen | 2,000 | 01 Dec, 2025 | |
| Cynthia M Butitta | 2,000 | 01 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Nov, 2025 | Cynthia M Butitta | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | James A. Jr. Robinson | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Stuart Holden | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Leana Wen | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Daniel George Wildman | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 19 Nov, 2025 | Mark Schoenberg | Ordinary Shares | D | 10,000 | $25.00 | 139,025 | D | S |
| 08 Oct, 2025 | Chris Degnan | Ordinary Shares | A | 4,483 | - | 4,483 | D | M |
| 08 Oct, 2025 | Chris Degnan | Ordinary Shares | D | 2,203 | $16.85 | 2,280 | D | S |
| 08 Sep, 2025 | Mark Schoenberg | Ordinary Shares | D | 871 | $19.11 | 149,025 | D | S |
| 08 Sep, 2025 | Jason Drew Smith | Ordinary Shares | D | 1,520 | $19.11 | 43,305 | D | S |
| 07 Sep, 2025 | Mark Schoenberg | Ordinary Shares | A | 1,667 | - | 149,896 | D | M |
| 07 Sep, 2025 | Jason Drew Smith | Ordinary Shares | A | 3,333 | - | 44,825 | D | M |
| 11 Aug, 2025 | Mark Schoenberg | Ordinary Shares | D | 10,000 | $17.69 | 148,229 | D | S |
| 28 Jul, 2025 | Mark Schoenberg | Ordinary Shares | A | 10,000 | - | 163,378 | D | M |
| 28 Jul, 2025 | Mark Schoenberg | Ordinary Shares | D | 5,149 | $19.14 | 158,229 | D | S |
| 28 Jul, 2025 | Jason Drew Smith | - | - | 49,014 | D | |||
| 28 Jul, 2025 | Jason Drew Smith | Ordinary Shares | A | 16,500 | - | 49,014 | D | M |
| 28 Jul, 2025 | Jason Drew Smith | Ordinary Shares | D | 7,522 | $19.14 | 41,492 | D | S |
| 28 Jul, 2025 | Jason Drew Smith | - | - | 41,492 | D | |||
| 09 Jun, 2025 | Mark Schoenberg | Ordinary Shares | D | 5,162 | $7.37 | 153,378 | D | S |